Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study

Risk-stratified therapy, which modifies treatment on the basis of clinical and biologic features, has improved 5-year overall survival of childhood acute lymphoblastic leukemia (ALL) to 90%, but its impact on long-term toxicity remains unknown. We assessed all-cause and health-related late mortality...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 38; no. 29; p. 3418
Main Authors:	Dixon, Stephanie B, Chen, Yan, Yasui, Yutaka, Pui, Ching-Hon, Hunger, Stephen P, Silverman, Lewis B, Ness, Kirsten K, Green, Daniel M, Howell, Rebecca M, Leisenring, Wendy M, Kadan-Lottick, Nina S, Krull, Kevin R, Oeffinger, Kevin C, Neglia, Joseph P, Mertens, Ann C, Hudson, Melissa M, Robison, Leslie L, Armstrong, Gregory T, Nathan, Paul C
Format:	Journal Article
Language:	English
Published:	United States 10.10.2020
Subjects:	Adolescent Adult Cancer Survivors - statistics & numerical data Child Child, Preschool Cognitive Dysfunction - epidemiology Cohort Studies Female Humans Male Middle Aged Morbidity Neoplasms, Second Primary - epidemiology Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Precursor Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy Retrospective Studies Young Adult
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!